Neurovascular Thrombectomy Devices Market 20262031

November 2025 | 210 pages | ID: N22E5B178F9BEN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Neurovascular Thrombectomy Devices Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.068 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Neurovascular Thrombectomy Devices Market.

This report delivers a comprehensive overview of the Neurovascular Thrombectomy Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neurovascular Thrombectomy Devices Market. The Neurovascular Thrombectomy Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –2031.

Neurovascular Thrombectomy Devices Market Scope:

By Product Type
  • Aspiration Thrombectomy Devices
  • Mechanical Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices
  • Others
By End User
  • Hospitals
  • Neuro-Catheterization Labs
  • Specialized Neurosurgery Centers
Key Players
  • Medtronic Plc
  • Johnson and Johnson
  • Penumbra Inc.
  • Stryker Corporation
  • Argon Medical Inc.
  • Teleflex Incorporated
  • Boston Scientific Corporation
  • Acandis GmbH
  • Edwards Lifesciences Corporation
  • Terumo Medical Corporation
  • Spectranetics Corporation(LIST NOT EXHAUSTIVE)
Major Highlights

This report delivers a comprehensive overview of the Neurovascular Thrombectomy Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neurovascular Thrombectomy Devices Market. The Neurovascular Thrombectomy Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Innovations and Developments
    4.1.1.2. The Growing Geriatric Population?
  4.1.2. Restraints
    4.1.2.1. High Cost
    4.1.2.2. Lack of Skilled Professionals
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Aspiration Thrombectomy Devices
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Mechanical Thrombectomy Devices
7.4. Ultrasonic Thrombectomy Devices
7.5. Others

8. BY END USER

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospitals
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Neuro-Catheterization Labs
8.4. Specialized Neurosurgery Centers

9. BY REGION

9.1. Introduction
  9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.2.5.1. The U.S.
    9.2.5.2. Canada
    9.2.5.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.3.5.1. Germany
    9.3.5.2. The U.K.
    9.3.5.3. France
    9.3.5.4. Italy
    9.3.5.5. Spain
    9.3.5.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.4.5.1. Brazil
    9.4.5.2. Argentina
    9.4.5.3. Rest of South America
9.5. Asia Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.5.5.1. China
    9.5.5.2. India
    9.5.5.3. Japan
    9.5.5.4. Australia
    9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. COMPETITIVE LANDSCAPE

10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking

11. COMPANY PROFILES

11.1. Medtronic Plc
  11.1.1. Company Overview
  11.1.2. Product Portfolio and Description
  11.1.3. Key Highlights
  11.1.4. Financial Overview
11.2. Johnson and Johnson
11.3. Penumbra Inc.
11.4. Stryker Corporation
11.5. Argon Medical Inc.
11.6. Teleflex Incorporated
11.7. Boston Scientific Corporation
11.8. Acandis GmbH
11.9. Edwards Lifesciences Corporation
11.10. Terumo Medical Corporation
11.11. Spectranetics Corporation(*LIST NOT EXHAUSTIVE)

12. DATAM INTELLIGENCE

12.1. Appendix
12.2. About Us and Services
12.3. Contact Us


More Publications